tm logo
APSAFE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 19 May 2023

Last Applicant/ Owned by

1533 Union Avenue

Pennsauken

NJ

08110

Serial Number

86670945 filed on 23rd Jun 2015

Registration Number

5096433 registered on 06th Dec 2016

in the Principal Register

Correspondent Address

Kathleen A. Tyrrell

Kathleen A. Tyrrell

66 E. MAIN STREET

Marlton NJ 08053-2141

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

APSAFE

Pharmaceutical and nutraceutical preparations for the treatment of or alleviation of symptoms associated with respiratory ailments and disorders, stomach ailments and disorders, allergic reactions, pain, inflammation, cough and cold

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and nutraceutical preparations for the treatment of or alleviation of symptoms associated with respiratory ailments and disorders, stomach ailments and disorders, allergic reactions, pain, inflammation, cough and cold


First Use Date in General

17th Sep 2015

First Use Date in Commerce

31st Jul 2016

Specimens


APSAFE specimenAPSAFE specimenAPSAFE specimenAPSAFE specimenAPSAFE specimen

Mark Details


Serial Number

No 86670945

Mark Type

No Service/Collective Mark

Attorney Docket Number

No AI0042TM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th May 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
19th May 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
19th May 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07th Nov 2022TEAS SECTION 8 & 15 RECEIVED
06th Dec 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06th Dec 2016REGISTERED-PRINCIPAL REGISTER
29th Oct 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28th Oct 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28th Oct 2016STATEMENT OF USE PROCESSING COMPLETE
28th Oct 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL